Abstract

CAS Article PubMed PubMed Central Google Scholar Download references Acknowledgements The authors thank all the investigators of the Lymphonie study group (Pascal Andreu, François Aptel, Marie Labruyère, Sébastien Prin (Department of Intensive Care, Dijon Bourgogne University Hospital, Dijon, France); Guillaume Beltramo, Philippe Bonniaud (Department of Pneumology, Dijon Bourgogne University Hospital, Dijon, France); Philip Bielefeld, Hervé Devilliers (Department of Internal Medicine and Systemic Diseases, Dijon Bourgogne University Hospital, Dijon, France); Bernard Bonnotte (Department of Internal Medicine and Clinical Immunology, Dijon Bourgogne University Hospital, Dijon, France); Marielle Buisson (Infectious Diseases Department, Dijon Bourgogne University Hospital, Dijon, France); Alain Putot (Geriatrics Internal Medicine Department, Dijon Bourgogne University Hospital, Dijon, France). Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome [RAW_REF_TEXT] Mathieu Blot 1,2 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Jean-Baptiste Bour3 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Jean Pierre Quenot2,4,5,6 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Abderrahmane Bourredjem5,6 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Maxime Nguyen2,7 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Julien Guy8 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Serge Monier2,9 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Marjolaine Georges10 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Audrey Large4 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Auguste Dargent2,4 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Alexandre Guilhem11 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Suzanne Mouries-Martin12 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Jeremy Barben13 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Belaid Bouhemad2,7 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Pierre‑Emmanuel Charles2,4 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Pascal Chavanet1,5,6 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Christine Binquet2,5,6 & [/RAW_REF_TEXT] [RAW_REF_TEXT] Lionel Piroth1,5,6 [/RAW_REF_TEXT] [RAW_REF_TEXT] for the LYMPHONIE Study Group [/RAW_REF_TEXT] Journal of Translational Medicine volume 19, Article number: 100 (2021) Cite this article [RAW_REF_TEXT] 114 Accesses [/RAW_REF_TEXT] [RAW_REF_TEXT] Metrics details [/RAW_REF_TEXT] The Original Article was published on 03 December 2020 Correction Open Access Published:08 March 2021 [/RAW_REF_TEXT] Correction to:

Details

Title
Correction to: The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
Author
Blot, Mathieu; Bour, Jean-Baptiste; Quenot, Jean Pierre; Bourredjem, Abderrahmane; Nguyen, Maxime; Julien, Guy; Monier, Serge; Georges, Marjolaine; Large, Audrey; Dargent, Auguste; Alexandre Guilhem; Mouries-Martin, Suzanne; Barben, Jeremy; Bouhemad, Belaid; Pierre‑Emmanuel Charles; Chavanet, Pascal
Pages
1-2
Section
Correction
Publication year
2021
Publication date
2021
Publisher
BioMed Central
e-ISSN
14795876
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2502919971
Copyright
© 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.